During the last session, InMed Pharmaceuticals Inc (NASDAQ:INM)’s traded shares were 3.39 million, with the beta value of the company hitting 0.52. At the end of the trading day, the stock’s price was $0.30, reflecting an intraday gain of 10.99% or $0.03. The 52-week high for the INM share is $2.08, that puts it down -593.33 from that peak though still a striking 13.33% gain since the share price plummeted to a 52-week low of $0.26. The company’s market capitalization is $1.01M, and the average trade volume was 307.35K shares over the past three months.
InMed Pharmaceuticals Inc (NASDAQ:INM) trade information
InMed Pharmaceuticals Inc (INM) registered a 10.99% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.99% in intraday trading to $0.30, hitting a weekly high. The stock’s 5-day price performance is 1.00%, and it has moved by -15.83% in 30 days. Based on these gigs, the overall price performance for the year is -74.54%.
InMed Pharmaceuticals Inc (INM) estimates and forecasts
In the rating firms’ projections, revenue will increase 31.00% compared to the previous financial year.
Revenue for the current quarter is expected to be $1.49 million as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to $1.79 million by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $1.03 million and $2.31 million respectively. In this case, analysts expect current quarter sales to grow by 44.10% and then drop by -22.60% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 39.17%.
INM Dividends
InMed Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
